This company has been marked as potentially delisted and may not be actively trading. NASDAQ:THTX Theratechnologies (THTX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Theratechnologies Stock (NASDAQ:THTX) Get Theratechnologies alerts:Sign Up Key Stats Today's Range$3.34▼$3.4050-Day Range$3.24▼$3.4252-Week Range$2.24▼$3.40Volume3.27 million shsAverage Volume506,857 shsMarket Capitalization$157.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Theratechnologies Inc. is a Canadian biopharmaceutical company focused on discovering, developing and commercializing innovative therapies to address metabolic and endocrine disorders. Headquartered in Montréal, Quebec, the company leverages its expertise in peptide-based molecules to target conditions with significant unmet medical needs, including those associated with aging, HIV-related lipodystrophy and non-alcoholic fatty liver disease (NAFLD). The company’s lead commercial product is Egrifta® (tesamorelin), a synthetic growth hormone-releasing factor analogue approved in the United States and Canada for reducing excess abdominal fat in HIV-infected patients with lipodystrophy. Egrifta marked the first regulatory approval of a therapy specifically indicated for this condition, and it continues to generate royalty and product sales through direct marketing in North America under Theratechnologies’ own commercialization infrastructure. Beyond its marketed therapy, Theratechnologies maintains an active R&D pipeline aimed at expanding the use of tesamorelin into additional metabolic indications such as NAFLD, as well as pursuing novel peptide candidates in preclinical and early-stage clinical development. The company has entered licensing and collaboration agreements with partners in North America, Europe and Asia to facilitate late-stage trials and potential regulatory filings in new markets. Founded in 1993, Theratechnologies is governed by a board of directors and led by a management team with deep experience in biotechnology, regulatory affairs and commercialization. The company operates primarily in Canada and the United States, while seeking strategic alliances to extend its geographic reach and accelerate the clinical advancement of its product candidates.AI Generated. May Contain Errors. Read More Receive THTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. THTX Stock News HeadlinesTheratechnologies Announces Completion of Acquisition by Future PakSeptember 25, 2025 | globenewswire.comTheratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future PakSeptember 16, 2025 | financialpost.comFRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.July 6 at 1:00 AM | Porter & Company (Ad)Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future PakSeptember 16, 2025 | globenewswire.comTheratechnologies shareholders approve proposed acquisition by Future PakSeptember 12, 2025 | msn.comTheratechnologies Shareholders Approve Acquisition by Future Pak AffiliateSeptember 12, 2025 | tipranks.comTheratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future PakSeptember 12, 2025 | financialpost.comFTheratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future PakSeptember 12, 2025 | globenewswire.comSee More Headlines THTX Stock Analysis - Frequently Asked Questions How were Theratechnologies' earnings last quarter? Theratechnologies Inc. (NASDAQ:THTX) announced its quarterly earnings data on Wednesday, July, 9th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.08. The firm earned $17.73 million during the quarter, compared to analyst estimates of $24.30 million. When did Theratechnologies' stock split? Theratechnologies's stock reverse split on Monday, July 31st 2023.The 1-4 reverse split was announced on Monday, July 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 31st 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. Does Theratechnologies have any subsidiaries? The following companies are subsidiaries of Theratechnologies: Katana, Pharma-G Inc., Theratechnologies Europe Inc., Theratechnologies Europe Limited, Theratechnologies Intercontinental Inc., and Theratechnologies U.S. Inc. What other stocks do shareholders of Theratechnologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Theratechnologies investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Novo Nordisk A/S (NVO), Adobe (ADBE) and Celestica (CLS). Company Calendar Last Earnings7/09/2025Today7/06/2026Fiscal Year End11/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (15m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 THTX's financial health is in the Green zone, according to TradeSmith. THTX has been in this zone for over 15 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:THTX CIK1512717 Webwww.theratech.com Phone(514) 336-7800Fax514-331-9691Employees140Year Founded1993Profitability EPS (Trailing Twelve Months)($0.19) Trailing P/E RatioN/A Forward P/E Ratio341.90 P/E GrowthN/ANet Income-$8.31 million Net Margins-10.85% Pretax Margin-8.09% Return on EquityN/A Return on Assets-9.83% Debt Debt-to-Equity RatioN/A Current Ratio0.84 Quick Ratio0.65 Sales & Book Value Annual Sales$84.38 million Price / Sales1.86 Cash FlowN/A Price / Cash FlowN/A Book Value($0.55) per share Price / Book-6.22Miscellaneous Outstanding Shares45,980,000Free FloatN/AMarket Cap$157.21 million OptionableOptionable Beta0.51 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:THTX) was last updated on 7/6/2026 by MarketBeat.com Staff. From Our PartnersThree companies about to leapfrog Nvidia [And transform the entire industry]The government just committed $200 billion to building computer chips on American soil - one of the largest te...Eagle Publishing | SponsoredAmazon, Google, Meta, and Microsoft just committed $700 billionAmazon, Google, Meta, and Microsoft have committed $700 billion this year alone to AI infrastructure - more th...True Market Insiders | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | Sponsored$2 an acre. They paid $412.Government land listed at $2 an acre sold for $412 - 206 times asking price. Demand got so intense the feds do...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THTX Stock Alerts